Exchange: NASDAQ·Updated 06:41 AM EDT
CMPS logo

CMPS COMPASS Pathways

$12.25
$0.35
(2.94%)
Pre-Market
Prev Close $11.90
EarningsNov 3
Mkt Cap$1.65B
Vol480.00

About CMPS

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.
61

Bullish Sentiment

How do you feel about CMPS?

Millionaire11
$CMPS we are at 4 month lows in a company that is going to be FDA approved in psychedelic medicine in maximum 3 months. Buy now or forever regret. These headlines will be insane. Many need these medicines. Everybody enjoy your day, smile through the ups and downs!
26
FBP
$CMPS $DFTX $HELP I see a lot of newbies to small cap bio and impatient folks here. Welcome! We are set for a banger eoy. For those with stones these are gifts
1
25
JusaVaan
$CMPS biotech is back! Waiting for the NDA to be finalized any day now. Then it’s CNPV 1-2 month timeline from filing until approval! Maybe still this year!
16
Millionaire11
$CMPS I think next week is a reversal. A very big change in sentiment all over the internet. People are starting to find this one. Get in now while it’s low. Next thing you know $15 —-> $18 —-> $22 —-> $25+
25
UncleJudd
$CMPS For anyone who worries that something is wrong with CMPS every time is dips ... They all move up and down together. Nothing has changed (disregard ATAI which sold itself out for peanuts)
13
PsychedelicBull
$CMPS a green Friday is nice to see. If it stays who knows. We are still a long long way from where this should/will be. $40-50 is not unrealistic. I do hope the fda approval goes smoothly. They could very easily throw a wrench into the psychedelic sector by making the REMS extremely difficult. I hope that is not the case. There is no reason psilocybin and lsd should not be available for people who struggle with depression, anxiety and trauma. Yes need to be careful with specific people and backgrounds but that does the same for certain antidepressants and plenty of other medicines in this realm. Side effects are actually quite minimal with psychedelics. 🍄🚀
1
16
PsychedelicBull
$CMPS moving on up towards nda and approval. It’s only a matter of time before this hits the mental health market. 🍄❤️
12
UncleJudd
$CMPS Don't discount the first mover/novelty hype cycle that propelled this to $59 in the beginning. It's all about to happen again with NDA submission and FDA approval.
18
BankOnTheFuture
$CMPS A reminder of what happened following the last time we dipped into the high 10s in late July. This time we take 15 for good and it becomes support.
11
cacci11
$CMPS there’s over $190M voting against this stock and it’s not budging below support levels. Spring is loaded. May the best short burn and die
11
ApsoKing
$CMPS Price today doesnt matter. If it went to 15 again, I still wouldnt sell. Its too close for everything to start happening fast. 5 or 6 months still....but dont short yourselves!
14
JusaVaan
$CMPS FOMO should start with soon-coming PR about NDA submission finalized. At that point investors must realize, that CNPV means only 1-2 months from NDA filing until approval. But the masses of new investors will come, when there’s worlwide news of first-ever psychedelic being approved by FDA as a medicine.
15
Canvasback33
$CMPS watching closely to add one last stack of shares before submission/approval. The herd still does not know/understand the whole story and remarkable opportunity this company’s molecule presents. Their trial structure, execution, outcomes and just as importantly compliance w FDA requirements was something every other company in the space will attempt to replicate. CMPS has set the standard. If you’re still unsure about this opp, you need to dig in.
15
HamBoneXoXo
$CMPS I have been a bit critical of kabir comments recently, but I firmly believe those who are buying these days will be handsomely rewarded if patient long term investors. This is a buy and park and forget story that will be a 2 to 4 bagger. Your money, your call. My strategy is gradual accumulation at these prices. And I won’t mind if it goes lower from here.
13
Markdjenzer
$CMPS Spravato Q3 sales up 36% YOY (624 Million vs. 459 Million) from $JNJ earnings report. 9 months sales up 40% (1,676 Million vs. 1,193 Million). Growth is still there. YTD free cash flow ~15.1 Billion. They have the funds for a buyout 👀
1
11
BankOnTheFuture
$CMPS For those that like numbers: "Encountering 1111 suggests you are on the right path, supported by the universe, spirit guides, or guardian angels."
10
Millionaire11
$CMPS shift in perspective. If I told you in March we would be down 20% in the last 2 weeks of September and that would have us sitting at $12.45 I think you would be mind blown. All the longs please relax. Bigger and better are coming our way. Be patient and watch this pendant play out.
14
LurkerLongtime
$CMPS under promise, over deliver. He is watching his words and behavior closely. That isn't a bad thing to me. Remember when Christian was all sunshine and rainbows about the long road to commericalization right before the LLY rug pull of a deal? I would rather Kabir appear reserved rather than "gung ho". That would be a red flag for a reputable CEO imo. Not worried, let's ride
13
PsychedelicBull
$CMPS 1.7 billion market cap is pretty laughable. In a couple years this will be in the multi billion revenue range and growing. 🍄🚀
13
Hindsight1989
$CMPS CEO said the following during TD conference: ”There is clearly an extraordinarily unlikely scenario where we get approval and federal rescheduling by the end of this year, and that's why we have consistently said we would be launch-ready by the end of this year.” While its unlikely approval and rescheduling happen before year end, the only way it’s even a remote possibility is if they finalize the NDA submission in October. My guess is NDA submission will be finalized by Oct 15.
13

Advertisement|Remove ads.